Specific binding agents of human angiopoietin-2

Details Specific binding agents of human angiopoietin-2 Specific binding agents of human angiopoietin-2

2006-11-21

2006-11-21

Gupta, Anish (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S012200, C514S013800, C514S015800, C514S016700, C514S017400, C530S324000, C530S325000, C530S326000, C530S327000, C530S328000, C530S329000, C530S330000

Reexamination Certificate

active

07138370

ABSTRACT:
Disclosed are peptides that bind to Ang-2. Also disclosed are peptibodies comprising the peptides, methods of making such peptides and peptibodies, and methods of treatment using such peptides and peptibodies.

REFERENCES:
patent: 5116964 (1992-05-01), Capon et al.
patent: 5428130 (1995-06-01), Capon et al.
patent: 5447860 (1995-09-01), Ziegler
patent: 5455165 (1995-10-01), Capon et al.
patent: 5514582 (1996-05-01), Capon et al.
patent: 5521073 (1996-05-01), Davis et al.
patent: 5643755 (1997-07-01), Davis et al.
patent: 5650490 (1997-07-01), Davis et al.
patent: 5814464 (1998-09-01), Davis et al.
patent: 5879672 (1999-03-01), Davis et al.
patent: 5955291 (1999-09-01), Alitalo et al.
patent: 5972338 (1999-10-01), Godowski et al.
patent: 6030831 (2000-02-01), Godowski et al.
patent: 6166185 (2000-12-01), Davis et al.
patent: 6291646 (2001-09-01), Sledziewski et al.
patent: 6323323 (2001-11-01), Sledziewski et al.
patent: 6455035 (2002-09-01), Suri et al.
patent: 2003/0236193 (2003-12-01), Oliner et al.
patent: WO 95/13387 (1995-05-01), None
patent: WO 95/21866 (1995-08-01), None
patent: WO 98/05779 (1998-02-01), None
patent: WO 199933865 (1999-07-01), None
patent: WO 99/43801 (1999-09-01), None
patent: WO 00/06195 (2000-02-01), None
patent: WO 200023082 (2000-04-01), None
patent: WO 00/57901 (2000-10-01), None
patent: WO 00/77037 (2000-12-01), None
patent: WO 0075323 (2000-12-01), None
patent: WO 01/62891 (2001-08-01), None
patent: WO 01/71042 (2001-09-01), None
patent: WO 2003030833 (2003-04-01), None
patent: WO 2003057134 (2003-07-01), None
Putaporntip et al. Diversity in the Thrombospondin-Related Adhesive Protein Gene (Trap—of Plasmodium Vivax, Gene 268, pp. 97-104 (2001).
Carmeliet, et al. “Angiogenesis in cancer and other diseases”Nature407(6801):249-57 (2000).
Siemeister, et al. “Two independent mechanisms essential for tumor angiogensis: inhibition of human melanoma xenograft growth by interfering with either the vascular endothelial growth factor receptor pathway or the tie-2 pathway” Cancer Res. 59(13): 3185-3191 (Jul. 1, 1999).
Lin Pengnian et al. “Inhibition of tumor angiogensis using a soluble receptor establishes a role for Tie2 in pathologic vascular growth” J. Clin. Invest. 100(8): 2072-2078 (1997).
Chao et al. (2000), Genomic Sequence for Arabidopsis thaliana BAC F1K23 from Chromosome I. Acc. No. Q9SHQe, EMBL/GenBank/DDBJ database, EMBL; AC007508, AAF 24543, Accessed Dec. 10, 2003.
Syed et al. (2001), “The Effects of Angiopoietin-1 and -2 on Tumor Growth and Angiogenesis in Human Colon Cancer,”Cancer Research61:1255-1259.
Coxon et al. (2000), “Inhibition of interleukin-1 but not tumor necrosis factor suppresses neovascularization in rat models of corneal angiogenesis and adjuvant arthritis,”Arthritis Rheum. 46:2604-2612.
Feige et al. (2000), “Anti-interleukin-1 and anti-tumor necrosis factor-α synergistically inhibit adjuvant arthritis in Lewis rats,”Cell Mol. Life Sci, 57:1457-1470.
Peacock et al. (1992), “Angiogenesis inhibition suppresses collagen arthritis,”J. Exp. Med. 175:1135-1138.
Peacock et al. (1995), “A novel angiogenesis inhibitor suppresses rat adjuvant arthritis,”Cell Immunol. 160:178-184.
Walsh et al. (2001), “Angiogenesis in the pathogenesis of inflammatory joint and lung diseases,”Arthritis Res. 3:147-153.
Connell et al. (2001),Ashley Publications Ltd. ISSN 1354-3776, pp. 1171-1203.

Affiliated with

Also associated with

Rating

Specific binding agents of human angiopoietin-2 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Specific binding agents of human angiopoietin-2, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Specific binding agents of human angiopoietin-2 will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3698452